chr16-715867-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000568223.7(METRN):āc.388T>Cā(p.Phe130Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000651 in 1,381,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000039 ( 0 hom., cov: 33)
Exomes š: 0.0000024 ( 0 hom. )
Consequence
METRN
ENST00000568223.7 missense
ENST00000568223.7 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 2.25
Genes affected
METRN (HGNC:14151): (meteorin, glial cell differentiation regulator) Meteorin regulates glial cell differentiation and promotes the formation of axonal networks during neurogenesis (Nishino et al., 2004 [PubMed 15085178]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.816
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METRN | NM_024042.4 | c.388T>C | p.Phe130Leu | missense_variant | 2/4 | ENST00000568223.7 | NP_076947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METRN | ENST00000568223.7 | c.388T>C | p.Phe130Leu | missense_variant | 2/4 | 1 | NM_024042.4 | ENSP00000455068.1 | ||
METRN | ENST00000219542.3 | c.340T>C | p.Phe114Leu | missense_variant | 2/3 | 2 | ENSP00000219542.3 | |||
METRN | ENST00000567076.5 | c.226T>C | p.Phe76Leu | missense_variant | 1/4 | 5 | ENSP00000459900.1 | |||
METRN | ENST00000570132.1 | n.105-9T>C | intron_variant | 3 | ENSP00000456647.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152012Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000244 AC: 3AN: 1229848Hom.: 0 Cov.: 31 AF XY: 0.00000501 AC XY: 3AN XY: 598910
GnomAD4 exome
AF:
AC:
3
AN:
1229848
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
598910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152012Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74256
GnomAD4 genome
AF:
AC:
6
AN:
152012
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2023 | The c.388T>C (p.F130L) alteration is located in exon 2 (coding exon 2) of the METRN gene. This alteration results from a T to C substitution at nucleotide position 388, causing the phenylalanine (F) at amino acid position 130 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Gain of MoRF binding (P = 0.1303);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at